Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity

Indoles aryl hydrocarbon receptor Microbiota pancreatic cancer T cells Tryptophan microbiome macrophage indoles CD8-Positive T-Lymphocytes Prognosis Pancreatic Neoplasms Mice Lymphocytes, Tumor-Infiltrating Receptors, Aryl Hydrocarbon Tumor-Associated Macrophages Immune Tolerance Tumor Microenvironment tumor microenvironment Animals Humans immunotherapy immune suppression metabolism Carcinoma, Pancreatic Ductal
DOI: 10.1016/j.immuni.2022.01.006 Publication Date: 2022-02-08T15:41:40Z
ABSTRACT
The aryl hydrocarbon receptor (AhR) is a sensor of products tryptophan metabolism and potent modulator immunity. Here, we examined the impact AhR in tumor-associated macrophage (TAM) function pancreatic ductal adenocarcinoma (PDAC). TAMs exhibited high activity Ahr-deficient macrophages developed an inflammatory phenotype. Deletion Ahr myeloid cells or pharmacologic inhibition reduced PDAC growth, improved efficacy immune checkpoint blockade, increased intra-tumoral frequencies IFNγ+CD8+ T cells. Macrophage was not required for this effect. Rather, dependent on Lactobacillus metabolization dietary to indoles. Removal TAM promoted accumulation TNFα+IFNγ+CD8+ cells; provision indoles blocked In patients with PDAC, AHR expression associated rapid disease progression mortality, as well immune-suppressive phenotype, suggesting conservation regulatory axis human disease.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (68)
CITATIONS (358)